Mäenpää, Jukka
55  results:
Search for persons X
?
1

AZD4604, An Inhaled, Selective JAK1 Inhibitor Reduces Fract..:

Jensen, Tina Jellesmark ; Larsson, Julia ; Mäenpää, Jukka...
Journal of Allergy and Clinical Immunology.  153 (2024)  2 - p. AB98 , 2024
 
?
4

Characterisation of pharmacokinetics, safety and tolerabili..:

Sadiq, Muhammad Waqas ; Asimus, Sara ; Belvisi, Maria G....
British Journal of Clinical Pharmacology.  88 (2021)  1 - p. 260-270 , 2021
 
?
5

Dipeptidyl Peptidase 1 Inhibitor AZD7986 Induces a Sustaine..:

Palmér, Robert ; Mäenpää, Jukka ; Jauhiainen, Alexandra...
Clinical Pharmacology & Therapeutics.  104 (2018)  6 - p. 1155-1164 , 2018
 
?
6

Metabolism of Ophthalmic Timolol: New Aspects of an Old Dru:

Volotinen, Marjo ; Hakkola, Jukka ; Pelkonen, Olavi..
Basic & Clinical Pharmacology & Toxicology.  108 (2011)  5 - p. 297-303 , 2011
 
?
7

Effects of Selective Serotonin Reuptake Inhibitors on Timol..:

Volotinen, Marjo ; Korjamo, Timo ; Tolonen, Ari...
Basic & Clinical Pharmacology & Toxicology.  106 (2010)  4 - p. 302-309 , 2010
 
?
8

Ophthalmic timolol in a hydrogel vehicle leads to minor int..:

Volotinen, Marjo ; Mäenpää, Jukka ; Kautiainen, Hannu...
European Journal of Pharmaceutical Sciences.  36 (2009)  2-3 - p. 292-296 , 2009
 
?
9

Improved systemic safety and risk–benefit ratio of topical ..:

Uusitalo, Hannu ; Kähönen, Mika ; Ropo, Auli...
Graefe's Archive for Clinical and Experimental Ophthalmology.  244 (2006)  11 - p. 1491-1496 , 2006
 
?
10

Association between low plasma levels of ophthalmic timolol..:

Nieminen, Tuomo ; Uusitalo, Hannu ; Turjanmaa, Väinö...
European Journal of Clinical Pharmacology.  61 (2005)  5-6 - p. 369-374 , 2005
 
?
11

Polymorphisms of genes CYP2D6, ADRB1 and GNAS1 in pharmacok..:

Nieminen, Tuomo ; Uusitalo, Hannu ; Mäenpää, Jukka...
European Journal of Clinical Pharmacology.  61 (2005)  11 - p. 811-819 , 2005
 
1-15